Targeting orphan G protein-coupled receptors for the treatment of diabetes and its complications: C-peptide and GPR146
出版年份 2016 全文链接
标题
Targeting orphan G protein-coupled receptors for the treatment of diabetes and its complications: C-peptide and GPR146
作者
关键词
-
出版物
JOURNAL OF INTERNAL MEDICINE
Volume 281, Issue 1, Pages 25-40
出版商
Wiley
发表日期
2016-06-16
DOI
10.1111/joim.12528
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Orexin signaling is necessary for hypoglycemia-induced prevention of conditioned place preference
- (2016) Oleg Otlivanchik et al. AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
- Adropin acts in brain to inhibit water drinking: potential interaction with the orphan G protein-coupled receptor, GPR19
- (2016) Lauren M. Stein et al. AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
- Neuronostatin acts via GPR107 to increase cAMP-independent PKA phosphorylation and proglucagon mRNA accumulation in pancreatic α-cells
- (2016) Mollisa M. Elrick et al. AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
- The expanding repertoire of receptor activity modifying protein (RAMP) function
- (2016) Klara R. Klein et al. CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Patient-reported outcome results in patients with type 2 diabetes treated with once-weekly dulaglutide: data from the AWARD phase III clinical trial programme
- (2016) M. Yu et al. DIABETES OBESITY & METABOLISM
- Once-weekly glucagon-like peptide-1 receptor agonist dulaglutide significantly decreases glycated haemoglobin compared with once-daily liraglutide in Japanese patients with type 2 diabetes: 52 weeks of treatment in a randomized phase III study
- (2016) M. Odawara et al. DIABETES OBESITY & METABOLISM
- Yhhu4488, a novel GPR40 agonist, promotes GLP-1 secretion and exerts anti-diabetic effect in rodent models
- (2015) Dan-yang Guo et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Safety, tolerability and effects on cardiometabolic risk factors of empagliflozin monotherapy in drug-naïve patients with type 2 diabetes: a double-blind extension of a Phase III randomized controlled trial
- (2015) Michael Roden et al. Cardiovascular Diabetology
- GPR40 agonists for the treatment of type 2 diabetes: life after ‘TAKing’ a hit
- (2015) A. D. Mancini et al. DIABETES OBESITY & METABOLISM
- Efficacy and safety of fasiglifam (TAK-875), a G protein-coupled receptor 40 agonist, in Japanese patients with type 2 diabetes inadequately controlled by diet and exercise: a randomized, double-blind, placebo-controlled, phase III trial
- (2015) K. Kaku et al. DIABETES OBESITY & METABOLISM
- C-peptide: New findings and therapeutic possibilities
- (2015) John Wahren et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- A 9-Month Toxicity and Toxicokinetic Assessment of Subcutaneous Pegylated Human C-peptide (CBX129801) in Cynomolgus Monkeys
- (2015) Dennis Naas et al. INTERNATIONAL JOURNAL OF TOXICOLOGY
- Relationship between serum C-peptide level and diabetic retinopathy according to estimated glomerular filtration rate in patients with type 2 diabetes
- (2015) Jin Ook Chung et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- Discovery of the Once-Weekly Glucagon-Like Peptide-1 (GLP-1) Analogue Semaglutide
- (2015) Jesper Lau et al. JOURNAL OF MEDICINAL CHEMISTRY
- Five-Year Efficacy and Safety Data of Exenatide Once Weekly
- (2015) Carol H. Wysham et al. MAYO CLINIC PROCEEDINGS
- Ghrelin and motilin receptors as drug targets for gastrointestinal disorders
- (2015) Gareth J. Sanger et al. Nature Reviews Gastroenterology & Hepatology
- The Physiology of Proinsulin C-Peptide: Unanswered Questions and a Proposed Model
- (2015) Gina L. C. Yosten et al. PHYSIOLOGY
- Once-weekly trelagliptin versus daily alogliptin in Japanese patients with type 2 diabetes: a randomised, double-blind, phase 3, non-inferiority study
- (2015) Nobuya Inagaki et al. Lancet Diabetes & Endocrinology
- GPR40 (FFAR1) – Combined Gs and Gq signaling in vitro is associated with robust incretin secretagogue action ex vivo and in vivo
- (2015) Maria Hauge et al. Molecular Metabolism
- Physiological effects and therapeutic potential of proinsulin C-peptide
- (2014) Gina L. C. Yosten et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Low O2-induced ATP release from erythrocytes of humans with type 2 diabetes is restored by physiological ratios of C-peptide and insulin
- (2014) Jennifer P. Richards et al. AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
- The apelin receptor: physiology, pathology, cell signalling, and ligand modulation of a peptide-activated class A GPCR
- (2014) Nigel A. Chapman et al. Biochemistry and Cell Biology
- Efficacy and Safety of Linagliptin in Subjects With Long-standing Type 2 Diabetes Mellitus (>10 Years): Evidence From Pooled Data of Randomized, Double-blind, Placebo-controlled, Phase III Trials
- (2014) Rosemarie Lajara et al. CLINICAL THERAPEUTICS
- A comparison of adding liraglutide versus a single daily dose of insulin aspart to insulin degludec in subjects with type 2 diabetes (BEGIN: VICTOZA ADD-ON)
- (2014) C. Mathieu et al. DIABETES OBESITY & METABOLISM
- Efficacy and safety of initial combination therapy with alogliptin plus metformin versus either as monotherapy in drug-naïve patients with type 2 diabetes: a randomized, double-blind, 6-month study
- (2014) R. E. Pratley et al. DIABETES OBESITY & METABOLISM
- Loss of MITF expression during human embryonic stem cell differentiation disrupts retinal pigment epithelium development and optic vesicle cell proliferation
- (2014) Elizabeth E. Capowski et al. HUMAN MOLECULAR GENETICS
- Increased Glucose Metabolism and Glycerolipid Formation by Fatty Acids and GPR40 Receptor Signaling Underlies the Fatty Acid Potentiation of Insulin Secretion
- (2014) Mahmoud El-Azzouny et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Beneficial effects of once-daily lixisenatide on overall and postprandial glycemic levels without significant excess of hypoglycemia in Type 2 diabetes inadequately controlled on a sulfonylurea with or without metformin (GetGoal-S)
- (2014) Julio Rosenstock et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- High-resolution structure of the human GPR40 receptor bound to allosteric agonist TAK-875
- (2014) Ankita Srivastava et al. NATURE
- Cell Models to Study Regulation of Cell Transformation in Pathologies of Retinal Pigment Epithelium
- (2014) Alla V. Kuznetsova et al. Journal of Ophthalmology
- Once-weekly albiglutide versus once-daily liraglutide in patients with type 2 diabetes inadequately controlled on oral drugs (HARMONY 7): a randomised, open-label, multicentre, non-inferiority phase 3 study
- (2014) Richard E Pratley et al. Lancet Diabetes & Endocrinology
- Synergistic effects of C-peptide and insulin on low O2-induced ATP release from human erythrocytes
- (2013) Jennifer P. Richards et al. AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
- Efficacy and Safety of Vildagliptin in New-Onset Diabetes After Kidney Transplantation-A Randomized, Double-Blind, Placebo-Controlled Trial
- (2013) M. Haidinger et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Prevention of VEGF-mediated microvascular permeability by C-peptide in diabetic mice
- (2013) Y.-C. Lim et al. CARDIOVASCULAR RESEARCH
- Orexin receptors: Multi-functional therapeutic targets for sleeping disorders, eating disorders, drug addiction, cancers and other physiological disorders
- (2013) Tian-Rui Xu et al. CELLULAR SIGNALLING
- Recent developments in biased agonism
- (2013) James W Wisler et al. CURRENT OPINION IN CELL BIOLOGY
- C-Peptide Activates AMPK and Prevents ROS-Mediated Mitochondrial Fission and Endothelial Apoptosis in Diabetes
- (2013) M. P. Bhatt et al. DIABETES
- Impact of C-Peptide Preservation on Metabolic and Clinical Outcomes in the Diabetes Control and Complications Trial
- (2013) J. M. Lachin et al. DIABETES
- A Critical Analysis of the Clinical Use of Incretin-Based Therapies: The benefits by far outweigh the potential risks
- (2013) M. A. Nauck DIABETES CARE
- A Critical Analysis of the Clinical Use of Incretin-Based Therapies: Are the GLP-1 therapies safe?
- (2013) P. C. Butler et al. DIABETES CARE
- Adding Once-Daily Lixisenatide for Type 2 Diabetes Inadequately Controlled With Newly Initiated and Continuously Titrated Basal Insulin Glargine
- (2013) Matthew C. Riddle et al. DIABETES CARE
- Efficacy and safety of lixisenatide once daily versus placebo in type 2 diabetes insufficiently controlled on pioglitazone (GetGoal-P)
- (2013) M. Pinget et al. DIABETES OBESITY & METABOLISM
- Liraglutide as Additional Treatment to Insulin in Obese Patients with Type 1 Diabetes Mellitus
- (2013) Nitesh Kuhadiya et al. Endocrine Practice
- Regulation of Na,K-ATPase β1-subunit in TGF-β2-mediated epithelial-to-mesenchymal transition in human retinal pigmented epithelial cells
- (2013) Sridevi Mony et al. EXPERIMENTAL EYE RESEARCH
- The retinal pigment epithelium: An important player of retinal disorders and regeneration
- (2013) Chikafumi Chiba EXPERIMENTAL EYE RESEARCH
- Biased Agonism as a Mechanism for Differential Signaling by Chemokine Receptors
- (2013) Sudarshan Rajagopal et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Evidence for an interaction between proinsulin C-peptide and GPR146
- (2013) Gina L C Yosten et al. JOURNAL OF ENDOCRINOLOGY
- The IUPHAR/BPS Guide to PHARMACOLOGY: an expert-driven knowledgebase of drug targets and their ligands
- (2013) Adam J. Pawson et al. NUCLEIC ACIDS RESEARCH
- DC260126: A Small-Molecule Antagonist of GPR40 that Protects against Pancreatic β-Cells Dysfunction in db/db Mice
- (2013) Peng Sun et al. PLoS One
- Selective CGRP and adrenomedullin peptide binding by tethered RAMP-calcitonin receptor-like receptor extracellular domain fusion proteins
- (2013) Heather E. Moad et al. PROTEIN SCIENCE
- Efficacy and safety of nateglinide plus vildagliptin combination therapy compared with switching to vildagliptin in type 2 diabetes patients inadequately controlled with nateglinide
- (2013) Kyoko Kudo-Fujimaki et al. Journal of Diabetes Investigation
- Novo Nordisk replies to BMJ investigation on incretins and pancreatic damage
- (2013) A. Moses BMJ-British Medical Journal
- Has pancreatic damage from glucagon suppressing diabetes drugs been underplayed?
- (2013) D. Cohen BMJ-British Medical Journal
- Evidence for an interaction of neuronostatin with the orphan G protein-coupled receptor, GPR107
- (2012) Gina L. C. Yosten et al. AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
- Inside-out, outside-in, and inside–outside-in: G protein signaling in integrin-mediated cell adhesion, spreading, and retraction
- (2012) Bo Shen et al. CURRENT OPINION IN CELL BIOLOGY
- The Clinical Potential of C-Peptide Replacement in Type 1 Diabetes
- (2012) J. Wahren et al. DIABETES
- Efficacy and Safety of Taspoglutide Monotherapy in Drug-Naive Type 2 Diabetic Patients After 24 Weeks of Treatment: Results of a randomized, double-blind, placebo-controlled phase 3 study (T-emerge 1)
- (2012) I. Raz et al. DIABETES CARE
- A multicentre, multinational, randomized, placebo-controlled, double-blind, phase 3 trial to evaluate the efficacy and safety of gemigliptin (LC15-0444) in patients with type 2 diabetes
- (2012) S. J. Yang et al. DIABETES OBESITY & METABOLISM
- Vildagliptin Added to Metformin on β-Cell Function After a Euglycemic Hyperinsulinemic and Hyperglycemic Clamp in Type 2 Diabetes Patients
- (2012) Giuseppe Derosa et al. Diabetes Technology & Therapeutics
- G protein-coupled receptor (GPR)40-dependent potentiation of insulin secretion in mouse islets is mediated by protein kinase D1
- (2012) M. Ferdaoussi et al. DIABETOLOGIA
- TAK-875 versus placebo or glimepiride in type 2 diabetes mellitus: a phase 2, randomised, double-blind, placebo-controlled trial
- (2012) Charles F Burant et al. LANCET
- Biased Agonism of the Angiotensin II Type 1 Receptor
- (2012) C. M. Godin et al. MINI-REVIEWS IN MEDICINAL CHEMISTRY
- A Potent Class of GPR40 Full Agonists Engages the EnteroInsular Axis to Promote Glucose Control in Rodents
- (2012) Jian Luo et al. PLoS One
- Ghrelin Expression in the Mouse Pancreas Defines a Unique Multipotent Progenitor Population
- (2012) Luis Arnes et al. PLoS One
- Molecular Mechanism of β-Arrestin-Biased Agonism at Seven-Transmembrane Receptors
- (2011) Eric Reiter et al. Annual Review of Pharmacology and Toxicology
- G Protein–Coupled Receptor Deorphanizations
- (2011) Olivier Civelli et al. Annual Review of Pharmacology and Toxicology
- Bromocriptine: A Sympatholytic, D2-Dopamine Agonist for the Treatment of Type 2 Diabetes
- (2011) R. A. DeFronzo DIABETES CARE
- Functional Selective Oxytocin-derived Agonists Discriminate between Individual G Protein Family Subtypes
- (2011) Marta Busnelli et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Applying label-free dynamic mass redistribution technology to frame signaling of G protein–coupled receptors noninvasively in living cells
- (2011) Ralf Schröder et al. Nature Protocols
- DC260126, a small-molecule antagonist of GPR40, improves insulin tolerance but not glucose tolerance in obese Zucker rats
- (2010) Xiaodong Zhang et al. BIOMEDICINE & PHARMACOTHERAPY
- Randomized Clinical Trial of Quick-Release Bromocriptine Among Patients With Type 2 Diabetes on Overall Safety and Cardiovascular Outcomes
- (2010) J. M. Gaziano et al. DIABETES CARE
- A multicenter, randomized, placebo-controlled, double-blind phase II trial evaluating the optimal dose, efficacy and safety of LC 15-0444 in patients with type 2 diabetes
- (2010) E. J. Rhee et al. DIABETES OBESITY & METABOLISM
- C-peptide and long-term complications of diabetes
- (2010) Patrizia Luppi et al. PEDIATRIC DIABETES
- The Tight Junction Associated Signalling Proteins ZO-1 and ZONAB Regulate Retinal Pigment Epithelium Homeostasis in Mice
- (2010) Anastasios Georgiadis et al. PLoS One
- Human Amniotic Fluid Promotes Retinal Pigmented Epithelial Cells' Trans-Differentiation into Rod Photoreceptors and Retinal Ganglion Cells
- (2010) Shima Ghaderi et al. STEM CELLS AND DEVELOPMENT
- Dimerization in GPCR mobility and signaling
- (2009) Martin J Lohse CURRENT OPINION IN PHARMACOLOGY
- Deletion of GPR40 Impairs Glucose-Induced Insulin Secretion In Vivo in Mice Without Affecting Intracellular Fuel Metabolism in Islets
- (2009) T. Alquier et al. DIABETES
- Mechanisms of biphasic insulin-granule exocytosis - roles of the cytoskeleton, small GTPases and SNARE proteins
- (2009) Z. Wang et al. JOURNAL OF CELL SCIENCE
- Regulation of G-Protein Signaling by RKTG via Sequestration of the G Subunit to the Golgi Apparatus
- (2009) Y. Jiang et al. MOLECULAR AND CELLULAR BIOLOGY
- Islet G protein-coupled receptors as potential targets for treatment of type 2 diabetes
- (2009) Bo Ahrén NATURE REVIEWS DRUG DISCOVERY
- AMPK in Health and Disease
- (2009) Gregory R. Steinberg et al. PHYSIOLOGICAL REVIEWS
- Pharmacokinetics, pharmacodynamics, and tolerability of the dipeptidyl peptidase IV inhibitor LC15-0444 in healthy Korean men: A dose—block-randomized, double-blind, placebo-controlled, ascending single-dose, phase I study
- (2008) Kyoung Soo Lim et al. CLINICAL THERAPEUTICS
- Gpr40 Is Expressed in Enteroendocrine Cells and Mediates Free Fatty Acid Stimulation of Incretin Secretion
- (2008) S. Edfalk et al. DIABETES
- Glucose-lowering activity of the dipeptidyl peptidase-4 inhibitor saxagliptin in drug-naive patients with type 2 diabetes
- (2008) J. Rosenstock et al. DIABETES OBESITY & METABOLISM
- Loss-of-Function Mutation of theGPR40Gene Associates with Abnormal Stimulated Insulin Secretion by Acting on Intracellular Calcium Mobilization
- (2008) Roberto Vettor et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search